{"gene":"GNAI1","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":1995,"finding":"Crystal structure of the Gαi1(GDP)β1γ2 heterotrimer resolved at 2.3 Å, revealing two non-overlapping contact regions between α and β subunits, an extended β/γ interface covering nearly all of γ, limited α/γ interaction, GTP-induced rearrangement of switch II causing subunit dissociation, and a circularized sevenfold β-propeller formed by WD repeats in the β subunit.","method":"X-ray crystallography (2.3 Å resolution)","journal":"Cell","confidence":"High","confidence_rationale":"Tier 1 — high-resolution crystal structure, foundational study replicated across the field","pmids":["8521505"],"is_preprint":false},{"year":2004,"finding":"Mammalian LGN (mPins) binds Gαi1 through its C-terminal GoLoco/GPR domain; Gαi1 binding displaces the intramolecular LGN interaction, acting as a conformational switch that recruits NuMA to the cell cortex during mitosis. Overexpression of Gαi1 or LGN causes pronounced metaphase spindle oscillations, establishing a Gαi1–LGN–NuMA axis in mitotic spindle positioning.","method":"Co-immunoprecipitation, FRET biosensor, overexpression phenotypic analysis in mammalian cells","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — reciprocal binding assays plus FRET biosensor plus defined cellular phenotype (spindle oscillation), strong mechanistic study","pmids":["15537540"],"is_preprint":false},{"year":1996,"finding":"RGS10 associates specifically with activated forms of Gαi-family members and acts as a GTPase-activating protein (GAP), potently and selectively increasing GTP hydrolytic activity of Gαi3, Gαz, and Gαo; it does not interact with Gαs, demonstrating selectivity within the Gαi subfamily.","method":"Co-immunoprecipitation with activated Gα subunits; in vitro GTPase assay with purified proteins","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with purified proteins plus co-IP, selectivity rigorously demonstrated","pmids":["8774883"],"is_preprint":false},{"year":2021,"finding":"Disease-associated Gln52Pro substitution in Gαi1 (and the analogous Gln52Pro/Gln52Arg in Gαo) abolishes GTP binding and GTP hydrolysis, disrupts interaction with partner proteins that recognize GDP- or GTP-loaded Gα, and markedly reduces plasma membrane localization of the mutant protein, shifting it away from the plasma membrane toward intracellular compartments.","method":"Biochemical GTPase/GTP-binding assays, co-immunoprecipitation with partner proteins, subcellular localization imaging in transfected cells","journal":"Cells","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal biochemical assays (GTP binding, hydrolysis, co-IP, localization) in a single rigorous study","pmids":["34685729"],"is_preprint":false},{"year":2025,"finding":"Four GNAI1 syndrome missense variants (T48K, T48I, C224Y, V332E) show increased dopamine potency at the D2 receptor and elevated constitutive Gαi1 activity (gain-of-function on D2R signaling) in Xenopus oocyte assays, while the G40C variant is unresponsive to D2R activation. All variants display reduced GTP-γ-S binding rates and undetectable GTP hydrolysis except T48I, which shows accelerated binding and hydrolysis, indicating that GNAI1 syndrome variants collectively disrupt GTP exchange.","method":"Xenopus laevis oocyte electrophysiology (GIRK channel assay for D2R/Gαi1 coupling), GTP-γ-S binding assay, GTP hydrolysis assay","journal":"Science Signaling","confidence":"High","confidence_rationale":"Tier 1 — in vitro functional reconstitution in oocytes plus biochemical GTP assays, multiple variants tested with clear mechanistic readouts","pmids":["41329793"],"is_preprint":false},{"year":2025,"finding":"GNAI1 is required for ciliogenesis in human ciliated cells. C. elegans orthologous GNAI1 variants T48I, K272R, A328P, and V334E disrupt cilia assembly and chemosensory function in AWC neurons; D175V exerts neuron-specific effects on cilia-dependent behaviors; M88V and I321T have no detectable impact. Human D173V, K270R, and A326P variants disrupt ciliary localization of Gαi1 in human ciliated cell lines, validating conserved ciliogenic roles.","method":"CRISPR-Cas9 knock-in in C. elegans; cilia morphology imaging; chemotaxis behavioral assay; ciliary localization by fluorescence microscopy in human ciliated cell lines","journal":"Genetics","confidence":"High","confidence_rationale":"Tier 2 — CRISPR knock-in variants in whole organism plus human cell validation with direct localization readout; multiple orthogonal cellular and behavioral assays","pmids":["41052774"],"is_preprint":false},{"year":2019,"finding":"GNAI1 and GNAI3 suppress colitis-associated tumorigenesis by blocking IL6 signaling; their absence leads to activation of NF-κB (via JAK2-TRAF6-TAK1-CHUK/IKKβ) and STAT3 (via JAK2), increased GNAI2 expression, IL6, and nitric oxide synthase 2 levels, and expansion of MDSCs. Immunoprecipitation and immunoblot analyses of colon tumor tissues and MEFs confirmed interactions of GNAI1 and GNAI3 with proteins in the IL6 signaling pathway.","method":"Double-knockout mouse model (DSS/AOM CAC model); immunoprecipitation; immunoblot; flow cytometry; conditional Gnai2 knockout rescue experiment","journal":"Gastroenterology","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis in vivo (DKO + conditional rescue) combined with co-IP/immunoblot pathway analysis; replicated across multiple experimental approaches","pmids":["30836096"],"is_preprint":false},{"year":2012,"finding":"GNAI1 suppresses migration and invasion of hepatocellular carcinoma (HCC) cells; it is post-transcriptionally repressed by miR-320a/c/d, which directly target GNAI1 and promote HCC cell migratory and invasive capacity in vitro.","method":"Lentiviral GNAI1 overexpression; siRNA knockdown; miRNA mimic transfection; Transwell migration/invasion assays; Western blot","journal":"Cancer Biology & Medicine","confidence":"Medium","confidence_rationale":"Tier 2 — loss- and gain-of-function with defined phenotypic readout (migration/invasion), miRNA targeting validated by protein level changes; single lab","pmids":["23691483"],"is_preprint":false},{"year":2022,"finding":"Puerarin directly binds Gαi1 (Gnai1) in podocytes, identified by drug affinity responsive target stability (DARTS) combined with mass spectrometry. By binding and inhibiting Gnai1, puerarin relieves inhibition of adenylyl cyclase, increasing cAMP production and activating PKA/CREB signaling to protect against high-glucose-induced podocyte apoptosis.","method":"DARTS-mass spectrometry (direct binding identification); cAMP ELISA; CREB phosphorylation immunoblot; PKA inhibitor (Rp-cAMP) rescue; CREB overexpression apoptosis assay","journal":"Journal of Cellular and Molecular Medicine","confidence":"Medium","confidence_rationale":"Tier 2 — direct binding identified by DARTS-MS, functional consequences validated by multiple downstream readouts; single lab","pmids":["35678269"],"is_preprint":false},{"year":2015,"finding":"Valproic acid induces miR-124, which represses GNAI1 protein expression; reduced GNAI1 relieves inhibition of adenylyl cyclase, elevating cAMP and increasing Bdnf mRNA expression. GNAI1 protein and Bdnf mRNA levels can be bidirectionally manipulated by miR-124 mimic or inhibitor.","method":"miRNA microarray; iTRAQ proteomics; miR-124 mimic/inhibitor transfection; Western blot; RT-qPCR","journal":"Neurochemistry International","confidence":"Medium","confidence_rationale":"Tier 3 — computational prediction validated by mimic/inhibitor experiments and protein-level measurement; single lab, no direct binding assay","pmids":["26519098"],"is_preprint":false},{"year":2023,"finding":"Neuroglobin (NGB) physically interacts with GNAI1 and reduces GNAI1 and p-EGFR expression, thereby inhibiting EGFR/AKT/ERK signaling and suppressing pancreatic cancer cell proliferation, migration, invasion, and EMT.","method":"Co-immunoprecipitation; Western blot; in vitro proliferation, migration, invasion assays; in vivo xenograft; RT-PCR","journal":"Biochemical and Biophysical Research Communications","confidence":"Medium","confidence_rationale":"Tier 3 — single co-IP plus downstream pathway analysis with phenotypic readout; single lab","pmids":["37141638"],"is_preprint":false},{"year":2024,"finding":"Exosomal miR-320d from colorectal cancer cells is transferred to vascular endothelial cells where it directly targets GNAI1, reducing its expression and thereby increasing JAK2/STAT3 activation and VEGFA production, promoting endothelial cell migration and angiogenesis.","method":"Exosome transfer experiments; miRNA mimic/inhibitor; GNAI1 knockdown/overexpression; JAK2/STAT3 pathway immunoblot; in vivo mouse tumor model","journal":"Cell Death & Disease","confidence":"Medium","confidence_rationale":"Tier 3 — functional miRNA targeting of GNAI1 with downstream pathway validation; single lab but multiple experimental approaches including in vivo","pmids":["39695099"],"is_preprint":false},{"year":2022,"finding":"In Ostm1-null mice, transcriptomic analysis of early DN1 T cell precursors identified a Foxo1-Klf2-S1pr1-Gnai1-Rac1 signaling axis regulated by Ostm1, placing Gnai1 within a T lymphopoiesis regulatory network; transgenic restoration of Ostm1 in DN1 cells rescued T cell subpopulations from ETP onwards.","method":"Transcriptome profiling of DN1 cells from Ostm1-null mice; transgenic rescue (cell-autonomous Ostm1 expression); flow cytometry of T cell subpopulations","journal":"iScience","confidence":"Low","confidence_rationale":"Tier 3 — transcriptomic axis identification without direct biochemical validation of Gnai1's role in the pathway","pmids":["35434560"],"is_preprint":false}],"current_model":"GNAI1 encodes Gαi1, an inhibitory heterotrimeric G protein α-subunit whose GDP-bound form assembles with Gβ1γ2 (crystal structure resolved at 2.3 Å); upon GTP binding, switch II rearrangement drives dissociation from βγ to engage effectors including adenylyl cyclase inhibition (raising cAMP when Gαi1 is blocked), JAK2/STAT3 and NF-κB pathways, and the spindle-positioning LGN–NuMA complex; RGS proteins (e.g., RGS10) act as GAPs to accelerate GTP hydrolysis and terminate signaling; GNAI1 syndrome-associated variants disrupt GTP exchange and hydrolysis, cause a net gain-of-function on D2R signaling, and impair ciliary localization of Gαi1, linking its ciliogenic and GPCR-transducing functions to neurodevelopmental pathology."},"narrative":{"teleology":[{"year":1995,"claim":"Resolution of the Gαi1·GDP–Gβ1γ2 heterotrimer crystal structure established the atomic basis for subunit assembly and revealed how GTP-induced switch II rearrangement drives subunit dissociation, providing the structural framework for all subsequent functional studies.","evidence":"X-ray crystallography at 2.3 Å resolution","pmids":["8521505"],"confidence":"High","gaps":["Structure captured the GDP-bound state; the active GTP-bound Gαi1 conformation with effectors was not resolved","No effector or GPCR complexes in the crystal"]},{"year":1996,"claim":"Identification of RGS10 as a selective GAP for Gαi-family members demonstrated that signal termination is actively regulated and subfamily-specific, not merely a function of intrinsic GTP hydrolysis rates.","evidence":"Co-immunoprecipitation with activated Gα subunits plus in vitro GTPase assays with purified proteins","pmids":["8774883"],"confidence":"High","gaps":["RGS10 selectivity was shown primarily for Gαi3, Gαz, and Gαo; direct GAP activity on Gαi1 specifically was not the focus","Cellular context for RGS10–Gαi1 regulation was not established"]},{"year":2004,"claim":"Discovery that Gαi1 binds the GoLoco domain of LGN to release NuMA and drive cortical spindle positioning revealed a GPCR-independent, cell-division-related function of Gαi1.","evidence":"Co-immunoprecipitation, FRET biosensor, and overexpression phenotypic analysis (spindle oscillations) in mammalian cells","pmids":["15537540"],"confidence":"High","gaps":["Whether endogenous Gαi1 versus other Gαi paralogs is the primary spindle-positioning subunit in vivo was not resolved","Upstream regulators of Gαi1-GDP loading at the cortex were not identified"]},{"year":2012,"claim":"Demonstration that GNAI1 suppresses hepatocellular carcinoma cell migration and is post-transcriptionally repressed by miR-320a/c/d linked Gαi1 loss to tumor invasiveness.","evidence":"Lentiviral overexpression, siRNA knockdown, miRNA mimic transfection, Transwell assays in HCC cell lines","pmids":["23691483"],"confidence":"Medium","gaps":["Direct miRNA–3′UTR binding validation (e.g., luciferase reporter) was not shown","In vivo metastasis data were lacking","Downstream effectors mediating migration suppression were not defined"]},{"year":2015,"claim":"Valproic acid–induced miR-124 was shown to repress GNAI1, relieving adenylyl cyclase inhibition and elevating cAMP/Bdnf, connecting Gαi1 to neurotrophin regulation via miRNA control.","evidence":"miRNA microarray, iTRAQ proteomics, miR-124 mimic/inhibitor transfection with Western blot and RT-qPCR readouts","pmids":["26519098"],"confidence":"Medium","gaps":["No direct miR-124 binding assay for GNAI1 3′UTR","Functional consequence on neuronal phenotype (beyond Bdnf mRNA) not tested"]},{"year":2019,"claim":"Genetic deletion of Gnai1 and Gnai3 in mice revealed that these subunits suppress colitis-associated tumorigenesis by restraining JAK2-mediated NF-κB and STAT3 activation downstream of IL-6, establishing Gαi1 as a tumor suppressor in inflammatory colon cancer.","evidence":"Double-knockout mouse model (DSS/AOM), co-IP, immunoblot, conditional Gnai2 rescue","pmids":["30836096"],"confidence":"High","gaps":["Individual contributions of Gnai1 versus Gnai3 were not fully separable","Direct physical interaction between Gαi1 and JAK2 was suggested by co-IP but structural details are absent"]},{"year":2021,"claim":"Biochemical characterization of the Gln52Pro disease variant showed abolished GTP binding and hydrolysis and mislocalization away from the plasma membrane, providing the first molecular explanation for how a GNAI1 syndrome mutation disrupts G protein cycling.","evidence":"GTPase/GTP-binding assays, co-IP with partner proteins, subcellular localization imaging in transfected cells","pmids":["34685729"],"confidence":"High","gaps":["Only one variant characterized in detail; spectrum of other syndrome variants not addressed","No structural data explaining why Q52P blocks nucleotide binding"]},{"year":2022,"claim":"Identification of puerarin as a direct Gαi1-binding ligand that relieves adenylyl cyclase inhibition in podocytes demonstrated pharmacological targeting of Gαi1 to increase cAMP/PKA/CREB signaling and protect against high-glucose-induced apoptosis.","evidence":"DARTS-mass spectrometry for direct binding; cAMP ELISA; CREB phosphorylation immunoblot; PKA inhibitor rescue","pmids":["35678269"],"confidence":"Medium","gaps":["Binding site on Gαi1 not mapped","Specificity of puerarin for Gαi1 versus other Gαi paralogs not determined","Single lab, awaits independent confirmation"]},{"year":2024,"claim":"Exosomal miR-320d from colorectal cancer cells was shown to target GNAI1 in endothelial cells, activating JAK2/STAT3 and VEGFA to promote angiogenesis, extending the GNAI1–JAK2/STAT3 axis to the tumor microenvironment.","evidence":"Exosome transfer, miRNA mimic/inhibitor, GNAI1 knockdown/overexpression, in vivo mouse tumor model","pmids":["39695099"],"confidence":"Medium","gaps":["Mechanism by which GNAI1 restrains JAK2 in endothelial cells (direct interaction vs. indirect) not resolved","Single lab study"]},{"year":2025,"claim":"Comprehensive functional profiling of GNAI1 syndrome variants revealed gain-of-function D2R signaling, disrupted GTP exchange/hydrolysis kinetics, and impaired ciliogenesis, unifying GPCR-transduction and ciliogenic defects as co-pathogenic mechanisms in the neurodevelopmental syndrome.","evidence":"Xenopus oocyte GIRK channel electrophysiology, GTPγS binding/hydrolysis assays, CRISPR knock-in C. elegans cilia phenotyping, human ciliated cell fluorescence microscopy","pmids":["41329793","41052774"],"confidence":"High","gaps":["Neuronal-specific consequences of ciliary and D2R signaling defects in mammalian brain not tested","How variant-specific biochemical defects map onto clinical severity is unknown","Therapeutic rescue strategies not explored"]},{"year":null,"claim":"Major open questions include which effector complexes Gαi1 engages in its GTP-bound form at atomic resolution, the paralog-specific contributions of Gαi1 versus Gαi2/Gαi3 in vivo, and whether pharmacological modulation of Gαi1 can ameliorate GNAI1 syndrome phenotypes.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of GTP-Gαi1 bound to an effector","Paralog-specific knockout phenotypes in the nervous system not fully characterized","No therapeutic intervention data for GNAI1 syndrome"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003924","term_label":"GTPase activity","supporting_discovery_ids":[0,2,3,4]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,6,8]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[4,6]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0,3,4]},{"term_id":"GO:0005929","term_label":"cilium","supporting_discovery_ids":[5]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[0,1,2,4,6,8]},{"term_id":"R-HSA-1640170","term_label":"Cell Cycle","supporting_discovery_ids":[1]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[6]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,5,6]}],"complexes":["Gαi1–Gβ1γ2 heterotrimer","LGN–NuMA spindle-positioning complex"],"partners":["GNB1","GNG2","GPSM2","NUMA1","RGS10","JAK2","NGB"],"other_free_text":[]},"mechanistic_narrative":"GNAI1 encodes Gαi1, an inhibitory heterotrimeric G protein α-subunit that cycles between GDP-bound (inactive) and GTP-bound (active) states to transduce signals from Gi-coupled GPCRs, principally by inhibiting adenylyl cyclase and thereby lowering intracellular cAMP [PMID:8521505, PMID:35678269]. In its GDP-bound form, Gαi1 assembles with Gβ1γ2 into a heterotrimer; GTP binding triggers switch II rearrangement and βγ dissociation, while RGS proteins such as RGS10 accelerate GTP hydrolysis to terminate signaling [PMID:8521505, PMID:8774883]. Beyond classical GPCR transduction, Gαi1 participates in mitotic spindle positioning through the LGN–NuMA cortical complex [PMID:15537540], suppresses colitis-associated tumorigenesis by restraining JAK2/STAT3 and NF-κB signaling [PMID:30836096], and is required for ciliogenesis, with disease-associated missense variants disrupting GTP exchange, GTP hydrolysis, D2 receptor coupling, and ciliary localization, defining a neurodevelopmental GNAI1 syndrome [PMID:41329793, PMID:41052774, PMID:34685729]."},"prefetch_data":{"uniprot":{"accession":"P63096","full_name":"Guanine nucleotide-binding protein G(i) subunit alpha-1","aliases":["Adenylate cyclase-inhibiting G alpha protein"],"length_aa":354,"mass_kda":40.4,"function":"Guanine nucleotide-binding proteins (G proteins) function as transducers downstream of G protein-coupled receptors (GPCRs) in numerous signaling cascades (PubMed:18434541, PubMed:33762731, PubMed:34239069, PubMed:35610220, PubMed:37935376, PubMed:37935377, PubMed:37963465, PubMed:38552625, PubMed:8774883, PubMed:38918398, PubMed:40080544). The alpha chain contains the guanine nucleotide binding site and alternates between an active, GTP-bound state and an inactive, GDP-bound state (PubMed:18434541, PubMed:8774883). Signaling by an activated GPCR promotes GDP release and GTP binding (PubMed:18434541, PubMed:8774883). The alpha subunit has a low GTPase activity that converts bound GTP to GDP, thereby terminating the signal (PubMed:18434541, PubMed:8774883). Both GDP release and GTP hydrolysis are modulated by numerous regulatory proteins (PubMed:18434541, PubMed:8774883). Signaling is mediated via effector proteins, such as adenylate cyclase: inhibits adenylate cyclase activity of ADCY1, ADCY5 and ADCY6, leading to decreased intracellular cAMP levels (PubMed:8119955). The inactive GDP-bound form prevents the association of RGS14 with centrosomes and is required for the translocation of RGS14 from the cytoplasm to the plasma membrane. Required for normal cytokinesis during mitosis (PubMed:17635935). Required for cortical dynein-dynactin complex recruitment during metaphase (PubMed:22327364)","subcellular_location":"Nucleus; Cytoplasm; Cell membrane; Cytoplasm, cytoskeleton, microtubule organizing center, centrosome; Cytoplasm, cell cortex; Membrane","url":"https://www.uniprot.org/uniprotkb/P63096/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GNAI1","classification":"Not Classified","n_dependent_lines":4,"n_total_lines":1208,"dependency_fraction":0.0033112582781456954},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GNAI1","total_profiled":1310},"omim":[{"mim_id":"621174","title":"CHOLESIN; CHLSN","url":"https://www.omim.org/entry/621174"},{"mim_id":"621173","title":"G PROTEIN-COUPLED RECEPTOR 146; GPR146","url":"https://www.omim.org/entry/621173"},{"mim_id":"619854","title":"NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, IMPAIRED SPEECH, AND BEHAVIORAL ABNORMALITIES; NEDHISB","url":"https://www.omim.org/entry/619854"},{"mim_id":"619344","title":"PURKINJE CELL PROTEIN 2; PCP2","url":"https://www.omim.org/entry/619344"},{"mim_id":"618558","title":"G PROTEIN SIGNALING MODULATOR 3; GPSM3","url":"https://www.omim.org/entry/618558"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Centrosome","reliability":"Supported"},{"location":"Principal piece","reliability":"Supported"},{"location":"Nucleoplasm","reliability":"Additional"},{"location":"Nucleoli","reliability":"Additional"},{"location":"Golgi apparatus","reliability":"Additional"},{"location":"Centriolar satellite","reliability":"Additional"},{"location":"Basal body","reliability":"Additional"},{"location":"Cytosol","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"brain","ntpm":37.1}],"url":"https://www.proteinatlas.org/search/GNAI1"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P63096","domains":[{"cath_id":"3.40.50.300","chopping":"38-60_181-339","consensus_level":"medium","plddt":96.1262,"start":38,"end":339},{"cath_id":"1.10.400.10","chopping":"62-174","consensus_level":"medium","plddt":95.8395,"start":62,"end":174}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P63096","model_url":"https://alphafold.ebi.ac.uk/files/AF-P63096-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P63096-F1-predicted_aligned_error_v6.png","plddt_mean":93.75},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GNAI1","jax_strain_url":"https://www.jax.org/strain/search?query=GNAI1"},"sequence":{"accession":"P63096","fasta_url":"https://rest.uniprot.org/uniprotkb/P63096.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P63096/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P63096"}},"corpus_meta":[{"pmid":"30836096","id":"PMC_30836096","title":"GNAI1 and GNAI3 Reduce Colitis-Associated Tumorigenesis in Mice by Blocking IL6 Signaling and Down-regulating Expression of GNAI2.","date":"2019","source":"Gastroenterology","url":"https://pubmed.ncbi.nlm.nih.gov/30836096","citation_count":80,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"23691483","id":"PMC_23691483","title":"GNAI1 Suppresses Tumor Cell Migration and Invasion and is Post-Transcriptionally Regulated by Mir-320a/c/d in Hepatocellular Carcinoma.","date":"2012","source":"Cancer biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23691483","citation_count":66,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"33473207","id":"PMC_33473207","title":"Variants in GNAI1 cause a syndrome associated with variable features including developmental delay, seizures, and hypotonia.","date":"2021","source":"Genetics in medicine : official journal of the American College of Medical Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/33473207","citation_count":30,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34685729","id":"PMC_34685729","title":"Pediatric Encephalopathy: Clinical, Biochemical and Cellular Insights into the Role of Gln52 of GNAO1 and GNAI1 for the Dominant Disease.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34685729","citation_count":27,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35678269","id":"PMC_35678269","title":"Puerarin attenuates diabetic kidney injury through interaction with Guanidine nucleotide-binding protein Gi subunit alpha-1 (Gnai1) subunit.","date":"2022","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/35678269","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"39695099","id":"PMC_39695099","title":"Exosomal miR-320d promotes angiogenesis and colorectal cancer metastasis via targeting GNAI1 to affect the JAK2/STAT3 signaling pathway.","date":"2024","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/39695099","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37141638","id":"PMC_37141638","title":"Neuroglobin inhibits pancreatic cancer proliferation and metastasis by targeting the GNAI1/EGFR/AKT/ERK signaling axis.","date":"2023","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/37141638","citation_count":14,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"25573302","id":"PMC_25573302","title":"Variants in SELL, MRPS36P2, TP63, DDB2, CACNA1H, ADAM19, GNAI1, CDH13 and GABRG2 interact to confer risk of acne in Chinese population.","date":"2015","source":"The Journal of dermatology","url":"https://pubmed.ncbi.nlm.nih.gov/25573302","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26519098","id":"PMC_26519098","title":"Valproic acid mediates miR-124 to down-regulate a novel protein target, GNAI1.","date":"2015","source":"Neurochemistry international","url":"https://pubmed.ncbi.nlm.nih.gov/26519098","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"27534535","id":"PMC_27534535","title":"Integrated analysis of omics data using microRNA-target mRNA network and PPI network reveals regulation of Gnai1 function in the spinal cord of Ews/Ewsr1 KO mice.","date":"2016","source":"BMC medical genomics","url":"https://pubmed.ncbi.nlm.nih.gov/27534535","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34819662","id":"PMC_34819662","title":"Novel de novo pathogenic variant in the GNAI1 gene as a cause of severe disorders of intellectual development.","date":"2021","source":"Journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/34819662","citation_count":5,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35434560","id":"PMC_35434560","title":"A Foxo1-Klf2-S1pr1-Gnai1-Rac1 signaling axis is a critical mediator of Ostm1 regulatory network in T lymphopoiesis.","date":"2022","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/35434560","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40394057","id":"PMC_40394057","title":"miRNA-200a suppresses GNAI1 and PLCB4 to modulate skin pigmentation in cashmere goats.","date":"2025","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/40394057","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41052774","id":"PMC_41052774","title":"Functional classification of GNAI1 disorder variants in Caenorhabditis elegans uncovers conserved and cell-specific mechanisms of dysfunction.","date":"2025","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/41052774","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40530109","id":"PMC_40530109","title":"Identification and functional analysis of GNAI1 as a biomarker associated with immune-related genes in pediatric acute myeloid leukemia.","date":"2025","source":"Translational cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/40530109","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41022165","id":"PMC_41022165","title":"SOGA1 drives ovarian cancer progression via regulation of GNAI1 and activation of the TNF/NF-κB pathway.","date":"2025","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/41022165","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40873676","id":"PMC_40873676","title":"Dysregulation of G protein subunits in autism: decreased GNAO1 and elevated GNAI1 levels in ASD.","date":"2025","source":"Frontiers in psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/40873676","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"40894620","id":"PMC_40894620","title":"Functional classification of GNAI1 disorder variants in C. elegans uncovers conserved and cell-specific mechanisms of dysfunction.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40894620","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41235373","id":"PMC_41235373","title":"A GNAI1 Pathogenic Variant Mimicking Cerebral Palsy: Expanding the Phenotypic Spectrum of GNAI1-Associated Neurodevelopmental Disorder.","date":"2025","source":"Clinical case reports","url":"https://pubmed.ncbi.nlm.nih.gov/41235373","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41797647","id":"PMC_41797647","title":"The protective role of FLI-1 in cardiac hypertrophy: Modulation of the IGF-1R/GNAI1/PLCG1 pathway.","date":"2026","source":"Histology and histopathology","url":"https://pubmed.ncbi.nlm.nih.gov/41797647","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"41329793","id":"PMC_41329793","title":"GNAI1 missense mutations associated with a neurodevelopmental syndrome modify Gαi1 function.","date":"2025","source":"Science signaling","url":"https://pubmed.ncbi.nlm.nih.gov/41329793","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.08.18.670960","title":"Functional classification of <i>GNAI1</i> disorder variants in <i>C. elegans</i> uncovers conserved and cell-specific mechanisms of dysfunction","date":"2025-08-22","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.18.670960","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12711604","id":"PMC_12711604","title":"Functional characterization of human receptors for short chain fatty acids and their role in polymorphonuclear cell activation.","date":"2003","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12711604","citation_count":1291,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12629551","id":"PMC_12629551","title":"Free fatty acids regulate insulin secretion from pancreatic beta cells through GPR40.","date":"2003","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/12629551","citation_count":1255,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11196645","id":"PMC_11196645","title":"Identification of the platelet ADP receptor targeted by antithrombotic drugs.","date":"2001","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/11196645","citation_count":1139,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8521505","id":"PMC_8521505","title":"The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2.","date":"1995","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/8521505","citation_count":1011,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25416956","id":"PMC_25416956","title":"A proteome-scale map of the human interactome network.","date":"2014","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25416956","citation_count":977,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12496284","id":"PMC_12496284","title":"The orphan G protein-coupled receptor GPR40 is activated by medium and long chain fatty acids.","date":"2002","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12496284","citation_count":908,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11076863","id":"PMC_11076863","title":"DNA cloning using in vitro site-specific recombination.","date":"2000","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11076863","citation_count":815,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11306274","id":"PMC_11306274","title":"Integrin-associated protein (CD47) and its ligands.","date":"2001","source":"Trends in cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/11306274","citation_count":719,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"22939629","id":"PMC_22939629","title":"A census of human soluble protein complexes.","date":"2012","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/22939629","citation_count":689,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19056867","id":"PMC_19056867","title":"Large-scale proteomics and phosphoproteomics of urinary exosomes.","date":"2008","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/19056867","citation_count":607,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"29899455","id":"PMC_29899455","title":"Structure of the µ-opioid receptor-Gi protein complex.","date":"2018","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/29899455","citation_count":553,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8208289","id":"PMC_8208289","title":"Structural determinants for activation of the alpha-subunit of a heterotrimeric G protein.","date":"1994","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8208289","citation_count":517,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21565611","id":"PMC_21565611","title":"Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways.","date":"2011","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/21565611","citation_count":507,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10973974","id":"PMC_10973974","title":"Molecular cloning and characterization of a novel type of histamine receptor preferentially expressed in leukocytes.","date":"2000","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/10973974","citation_count":481,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"19047060","id":"PMC_19047060","title":"Lactate inhibits lipolysis in fat cells through activation of an orphan G-protein-coupled receptor, GPR81.","date":"2008","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/19047060","citation_count":470,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"20360068","id":"PMC_20360068","title":"Systematic analysis of human protein complexes identifies chromosome segregation proteins.","date":"2010","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/20360068","citation_count":421,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"10506573","id":"PMC_10506573","title":"The chemokine SDF-1alpha triggers CXCR4 receptor dimerization and activates the JAK/STAT pathway.","date":"1999","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/10506573","citation_count":415,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26344197","id":"PMC_26344197","title":"Panorama of ancient metazoan macromolecular complexes.","date":"2015","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/26344197","citation_count":407,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11916537","id":"PMC_11916537","title":"Multiplicity of mechanisms of serotonin receptor signal transduction.","date":"2001","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/11916537","citation_count":361,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21726808","id":"PMC_21726808","title":"Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase.","date":"2011","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/21726808","citation_count":337,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15537540","id":"PMC_15537540","title":"Mammalian Pins is a conformational switch that links NuMA to heterotrimeric G proteins.","date":"2004","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/15537540","citation_count":321,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8774883","id":"PMC_8774883","title":"RGS10 is a selective activator of G alpha i GTPase activity.","date":"1996","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/8774883","citation_count":321,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":13190,"output_tokens":2531,"usd":0.038768},"stage2":{"model":"claude-opus-4-6","input_tokens":5886,"output_tokens":2926,"usd":0.15387},"total_usd":0.425507,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":24646,"output_tokens":3504,"usd":0.063249},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":7276,"output_tokens":3068,"usd":0.16962}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2019,\n      \"finding\": \"GNAI1 and GNAI3 interact with proteins in the IL6 signaling pathway (shown by immunoprecipitation), and their absence leads to activation of NF-κB via JAK2-TRAF6-TAK1-CHUK/IKKβ and STAT3 via JAK2, resulting in upregulation of GNAI2, IL6ST/GP130, and nitric oxide synthase 2, and expansion of MDSCs. Conditional disruption of Gnai2 in CD11c+ cells of GNAI1/3-DKO mice prevented NF-κB and STAT3 activation, placing GNAI2 downstream of GNAI1/3 loss in the IL6 signaling axis.\",\n      \"method\": \"Immunoprecipitation, immunoblot, genetic epistasis (conditional KO mice), flow cytometry, IL6 antibody blockade\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, multiple genetic models with defined cellular phenotypes, antibody rescue, replicated across in vitro and in vivo\",\n      \"pmids\": [\"30836096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GNAI1 suppresses migration and invasion of hepatocellular carcinoma cells, and is post-transcriptionally regulated by miR-320a/c/d which target GNAI1 to promote HCC cell migratory and invasive capacity.\",\n      \"method\": \"Lentiviral overexpression, siRNA knockdown, miRNA mimic transfection, Western blot, Transwell assay\",\n      \"journal\": \"Cancer biology & medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD/OE with defined cellular phenotype; single lab\",\n      \"pmids\": [\"23691483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Disease-associated Gln52 mutations in GNAI1 (Gαi1[Gln52Pro]) abolish GTP binding and hydrolysis (the fundamental catalytic activity of Gα proteins), disrupt interactions with partner proteins that recognize the GDP-loaded or GTP-loaded forms, and reduce plasma membrane localization of Gαi1, resulting in aberrant intracellular distribution.\",\n      \"method\": \"Biochemical GTP binding/hydrolysis assays, co-immunoprecipitation with partner proteins, cellular localization imaging\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assays plus cellular localization and protein interaction studies with functional mutants\",\n      \"pmids\": [\"34685729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Puerarin directly binds GNAI1 (identified by drug affinity responsive target stability assay combined with mass spectrometry), and inhibiting GNAI1 increases cAMP production and activates the PKA/CREB pathway in podocytes, protecting against high-glucose-induced apoptosis.\",\n      \"method\": \"DARTS-MS (drug affinity responsive target stability + mass spectrometry), cAMP measurement, CREB phosphorylation assay, PKA inhibitor (Rp-cAMP), CREB overexpression, in vivo mouse model\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding identified by DARTS-MS, functional pathway validated by inhibitor and OE experiments; single lab\",\n      \"pmids\": [\"35678269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Valproic acid induces miR-124, which represses GNAI1 protein expression; reduced GNAI1 (an adenylate cyclase inhibitor) leads to elevated cAMP and increased Bdnf expression, defining a miR-124→GNAI1→cAMP→BDNF pathway.\",\n      \"method\": \"miRNA microarray, iTRAQ proteomics, miR-124 mimic/inhibitor transfection, Western blot, qRT-PCR\",\n      \"journal\": \"Neurochemistry international\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — predicted by in silico then validated with miRNA mimics/inhibitors; single lab, moderate methods\",\n      \"pmids\": [\"26519098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Neuroglobin (NGB) physically binds GNAI1 (shown by co-IP) and reduces GNAI1 and p-EGFR levels, thereby inhibiting EGFR/AKT/ERK signaling, suppressing pancreatic cancer cell proliferation and metastasis.\",\n      \"method\": \"Co-immunoprecipitation, Western blot, in vitro proliferation/invasion/migration assays, in vivo xenograft\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single Co-IP with functional follow-up; single lab\",\n      \"pmids\": [\"37141638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Exosomal miR-320d from colorectal cancer cells targets GNAI1 in vascular endothelial cells, reducing GNAI1 levels and thereby increasing JAK2/STAT3 activation and VEGFA production, enhancing endothelial cell migration and angiogenesis.\",\n      \"method\": \"miRNA mimic/inhibitor transfection, luciferase reporter assay (implied by targeting), Western blot, endothelial cell migration/tube formation assays, in vivo tumor model\",\n      \"journal\": \"Cell death & disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional target validation with defined downstream signaling phenotype; single lab\",\n      \"pmids\": [\"39695099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GNAI1 is required for ciliogenesis in human ciliated cells. Patient-variant GNAI1 proteins (D173V, K270R, A326P) fail to localize properly to cilia in human ciliated cell lines; corresponding C. elegans orthologous variants (T48I, K272R, A328P, V334E) disrupt both cilia assembly and function in AWC neurons, while D175V has neuron-specific effects on cilia-dependent sensory behaviors.\",\n      \"method\": \"CRISPR-Cas9 editing in C. elegans, cilia morphology assays, behavioral (chemotaxis) assays, ciliary localization imaging in human ciliated cell lines\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR-edited variants in vivo plus human cell line validation; multiple orthogonal readouts; strong mechanistic resolution across variant classes\",\n      \"pmids\": [\"41052774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Five GNAI1 syndrome-associated missense variants (T48K, T48I, C224Y, V332E, G40C) alter Gαi1 biochemical function: T48K, T48I, C224Y, and V332E show reduced GTP-γ-S binding rates and undetectable GTP hydrolysis but cause gain-of-function increases in dopamine potency at D2R and elevated constitutive G protein activity; G40C is unresponsive to D2R activation. T48I alone shows more rapid GTP binding and hydrolysis.\",\n      \"method\": \"GTP-γ-S binding assay, GTP hydrolysis assay, Xenopus laevis oocyte expression system with D2R co-expression, constitutive activity measurements, in silico modeling\",\n      \"journal\": \"Science signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro enzymatic assays (GTP binding/hydrolysis) plus functional receptor signaling assays with multiple variant comparisons\",\n      \"pmids\": [\"41329793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"miRNA-200a directly targets the 3'UTR of GNAI1 (confirmed by dual-luciferase assay with wild-type and mutant plasmids), reducing GNAI1 expression and modulating skin pigmentation/melanogenesis.\",\n      \"method\": \"Dual-luciferase reporter assay (wild-type vs. mutant 3'UTR), miRNA mimic/inhibitor transfection, RT-qPCR, Western blot, in vivo antagomiR injection in mice\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct 3'UTR binding confirmed by luciferase with mutant control, in vivo validation; single lab\",\n      \"pmids\": [\"40394057\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNAI1 encodes the inhibitory Gα subunit Gαi1, which inhibits adenylate cyclase to reduce cAMP/PKA/CREB signaling; it also suppresses IL6-driven JAK2-NF-κB/STAT3 signaling, is required for ciliogenesis and ciliary localization in neurons, and disease-causing variants disrupt GTP binding/hydrolysis and GPCR coupling, with gain-of-function effects on dopamine D2R signaling underlying the GNAI1 neurodevelopmental syndrome.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1995,\n      \"finding\": \"Crystal structure of the Gαi1(GDP)β1γ2 heterotrimer resolved at 2.3 Å, revealing two non-overlapping contact regions between α and β subunits, an extended β/γ interface covering nearly all of γ, limited α/γ interaction, GTP-induced rearrangement of switch II causing subunit dissociation, and a circularized sevenfold β-propeller formed by WD repeats in the β subunit.\",\n      \"method\": \"X-ray crystallography (2.3 Å resolution)\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — high-resolution crystal structure, foundational study replicated across the field\",\n      \"pmids\": [\"8521505\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"Mammalian LGN (mPins) binds Gαi1 through its C-terminal GoLoco/GPR domain; Gαi1 binding displaces the intramolecular LGN interaction, acting as a conformational switch that recruits NuMA to the cell cortex during mitosis. Overexpression of Gαi1 or LGN causes pronounced metaphase spindle oscillations, establishing a Gαi1–LGN–NuMA axis in mitotic spindle positioning.\",\n      \"method\": \"Co-immunoprecipitation, FRET biosensor, overexpression phenotypic analysis in mammalian cells\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal binding assays plus FRET biosensor plus defined cellular phenotype (spindle oscillation), strong mechanistic study\",\n      \"pmids\": [\"15537540\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1996,\n      \"finding\": \"RGS10 associates specifically with activated forms of Gαi-family members and acts as a GTPase-activating protein (GAP), potently and selectively increasing GTP hydrolytic activity of Gαi3, Gαz, and Gαo; it does not interact with Gαs, demonstrating selectivity within the Gαi subfamily.\",\n      \"method\": \"Co-immunoprecipitation with activated Gα subunits; in vitro GTPase assay with purified proteins\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified proteins plus co-IP, selectivity rigorously demonstrated\",\n      \"pmids\": [\"8774883\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Disease-associated Gln52Pro substitution in Gαi1 (and the analogous Gln52Pro/Gln52Arg in Gαo) abolishes GTP binding and GTP hydrolysis, disrupts interaction with partner proteins that recognize GDP- or GTP-loaded Gα, and markedly reduces plasma membrane localization of the mutant protein, shifting it away from the plasma membrane toward intracellular compartments.\",\n      \"method\": \"Biochemical GTPase/GTP-binding assays, co-immunoprecipitation with partner proteins, subcellular localization imaging in transfected cells\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal biochemical assays (GTP binding, hydrolysis, co-IP, localization) in a single rigorous study\",\n      \"pmids\": [\"34685729\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Four GNAI1 syndrome missense variants (T48K, T48I, C224Y, V332E) show increased dopamine potency at the D2 receptor and elevated constitutive Gαi1 activity (gain-of-function on D2R signaling) in Xenopus oocyte assays, while the G40C variant is unresponsive to D2R activation. All variants display reduced GTP-γ-S binding rates and undetectable GTP hydrolysis except T48I, which shows accelerated binding and hydrolysis, indicating that GNAI1 syndrome variants collectively disrupt GTP exchange.\",\n      \"method\": \"Xenopus laevis oocyte electrophysiology (GIRK channel assay for D2R/Gαi1 coupling), GTP-γ-S binding assay, GTP hydrolysis assay\",\n      \"journal\": \"Science Signaling\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro functional reconstitution in oocytes plus biochemical GTP assays, multiple variants tested with clear mechanistic readouts\",\n      \"pmids\": [\"41329793\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"GNAI1 is required for ciliogenesis in human ciliated cells. C. elegans orthologous GNAI1 variants T48I, K272R, A328P, and V334E disrupt cilia assembly and chemosensory function in AWC neurons; D175V exerts neuron-specific effects on cilia-dependent behaviors; M88V and I321T have no detectable impact. Human D173V, K270R, and A326P variants disrupt ciliary localization of Gαi1 in human ciliated cell lines, validating conserved ciliogenic roles.\",\n      \"method\": \"CRISPR-Cas9 knock-in in C. elegans; cilia morphology imaging; chemotaxis behavioral assay; ciliary localization by fluorescence microscopy in human ciliated cell lines\",\n      \"journal\": \"Genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR knock-in variants in whole organism plus human cell validation with direct localization readout; multiple orthogonal cellular and behavioral assays\",\n      \"pmids\": [\"41052774\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GNAI1 and GNAI3 suppress colitis-associated tumorigenesis by blocking IL6 signaling; their absence leads to activation of NF-κB (via JAK2-TRAF6-TAK1-CHUK/IKKβ) and STAT3 (via JAK2), increased GNAI2 expression, IL6, and nitric oxide synthase 2 levels, and expansion of MDSCs. Immunoprecipitation and immunoblot analyses of colon tumor tissues and MEFs confirmed interactions of GNAI1 and GNAI3 with proteins in the IL6 signaling pathway.\",\n      \"method\": \"Double-knockout mouse model (DSS/AOM CAC model); immunoprecipitation; immunoblot; flow cytometry; conditional Gnai2 knockout rescue experiment\",\n      \"journal\": \"Gastroenterology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis in vivo (DKO + conditional rescue) combined with co-IP/immunoblot pathway analysis; replicated across multiple experimental approaches\",\n      \"pmids\": [\"30836096\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"GNAI1 suppresses migration and invasion of hepatocellular carcinoma (HCC) cells; it is post-transcriptionally repressed by miR-320a/c/d, which directly target GNAI1 and promote HCC cell migratory and invasive capacity in vitro.\",\n      \"method\": \"Lentiviral GNAI1 overexpression; siRNA knockdown; miRNA mimic transfection; Transwell migration/invasion assays; Western blot\",\n      \"journal\": \"Cancer Biology & Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss- and gain-of-function with defined phenotypic readout (migration/invasion), miRNA targeting validated by protein level changes; single lab\",\n      \"pmids\": [\"23691483\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Puerarin directly binds Gαi1 (Gnai1) in podocytes, identified by drug affinity responsive target stability (DARTS) combined with mass spectrometry. By binding and inhibiting Gnai1, puerarin relieves inhibition of adenylyl cyclase, increasing cAMP production and activating PKA/CREB signaling to protect against high-glucose-induced podocyte apoptosis.\",\n      \"method\": \"DARTS-mass spectrometry (direct binding identification); cAMP ELISA; CREB phosphorylation immunoblot; PKA inhibitor (Rp-cAMP) rescue; CREB overexpression apoptosis assay\",\n      \"journal\": \"Journal of Cellular and Molecular Medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — direct binding identified by DARTS-MS, functional consequences validated by multiple downstream readouts; single lab\",\n      \"pmids\": [\"35678269\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Valproic acid induces miR-124, which represses GNAI1 protein expression; reduced GNAI1 relieves inhibition of adenylyl cyclase, elevating cAMP and increasing Bdnf mRNA expression. GNAI1 protein and Bdnf mRNA levels can be bidirectionally manipulated by miR-124 mimic or inhibitor.\",\n      \"method\": \"miRNA microarray; iTRAQ proteomics; miR-124 mimic/inhibitor transfection; Western blot; RT-qPCR\",\n      \"journal\": \"Neurochemistry International\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — computational prediction validated by mimic/inhibitor experiments and protein-level measurement; single lab, no direct binding assay\",\n      \"pmids\": [\"26519098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"Neuroglobin (NGB) physically interacts with GNAI1 and reduces GNAI1 and p-EGFR expression, thereby inhibiting EGFR/AKT/ERK signaling and suppressing pancreatic cancer cell proliferation, migration, invasion, and EMT.\",\n      \"method\": \"Co-immunoprecipitation; Western blot; in vitro proliferation, migration, invasion assays; in vivo xenograft; RT-PCR\",\n      \"journal\": \"Biochemical and Biophysical Research Communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single co-IP plus downstream pathway analysis with phenotypic readout; single lab\",\n      \"pmids\": [\"37141638\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Exosomal miR-320d from colorectal cancer cells is transferred to vascular endothelial cells where it directly targets GNAI1, reducing its expression and thereby increasing JAK2/STAT3 activation and VEGFA production, promoting endothelial cell migration and angiogenesis.\",\n      \"method\": \"Exosome transfer experiments; miRNA mimic/inhibitor; GNAI1 knockdown/overexpression; JAK2/STAT3 pathway immunoblot; in vivo mouse tumor model\",\n      \"journal\": \"Cell Death & Disease\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — functional miRNA targeting of GNAI1 with downstream pathway validation; single lab but multiple experimental approaches including in vivo\",\n      \"pmids\": [\"39695099\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In Ostm1-null mice, transcriptomic analysis of early DN1 T cell precursors identified a Foxo1-Klf2-S1pr1-Gnai1-Rac1 signaling axis regulated by Ostm1, placing Gnai1 within a T lymphopoiesis regulatory network; transgenic restoration of Ostm1 in DN1 cells rescued T cell subpopulations from ETP onwards.\",\n      \"method\": \"Transcriptome profiling of DN1 cells from Ostm1-null mice; transgenic rescue (cell-autonomous Ostm1 expression); flow cytometry of T cell subpopulations\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — transcriptomic axis identification without direct biochemical validation of Gnai1's role in the pathway\",\n      \"pmids\": [\"35434560\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GNAI1 encodes Gαi1, an inhibitory heterotrimeric G protein α-subunit whose GDP-bound form assembles with Gβ1γ2 (crystal structure resolved at 2.3 Å); upon GTP binding, switch II rearrangement drives dissociation from βγ to engage effectors including adenylyl cyclase inhibition (raising cAMP when Gαi1 is blocked), JAK2/STAT3 and NF-κB pathways, and the spindle-positioning LGN–NuMA complex; RGS proteins (e.g., RGS10) act as GAPs to accelerate GTP hydrolysis and terminate signaling; GNAI1 syndrome-associated variants disrupt GTP exchange and hydrolysis, cause a net gain-of-function on D2R signaling, and impair ciliary localization of Gαi1, linking its ciliogenic and GPCR-transducing functions to neurodevelopmental pathology.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GNAI1 encodes the inhibitory heterotrimeric G protein α subunit Gαi1, which functions as a GTPase that couples to GPCRs to inhibit adenylyl cyclase and suppress cAMP/PKA/CREB signaling [PMID:35678269, PMID:26519098]. Beyond canonical cAMP regulation, GNAI1 interacts with IL-6 signaling pathway components and restrains JAK2-dependent NF-κB and STAT3 activation; loss of GNAI1 (with GNAI3) de-represses this axis, driving inflammatory gene expression and myeloid-derived suppressor cell expansion [PMID:30836096, PMID:39695099]. GNAI1 is required for ciliogenesis and proper ciliary localization, and disease-associated missense variants disrupt GTP binding/hydrolysis, impair GPCR coupling, and paradoxically produce gain-of-function enhancement of dopamine D2 receptor signaling, establishing the molecular basis of the GNAI1 neurodevelopmental syndrome [PMID:34685729, PMID:41329793, PMID:41052774]. GNAI1 expression is post-transcriptionally regulated by multiple miRNAs including miR-124, miR-200a, and the miR-320 family, linking its abundance to diverse phenotypic outputs including BDNF expression, melanogenesis, and cancer cell migration [PMID:26519098, PMID:40394057, PMID:23691483].\",\n  \"teleology\": [\n    {\n      \"year\": 2012,\n      \"claim\": \"Whether GNAI1 influences cell motility beyond its canonical adenylyl cyclase inhibition was unknown; knockdown and overexpression experiments established that GNAI1 suppresses hepatocellular carcinoma cell migration and invasion, and that this function is regulated by miR-320a/c/d targeting of GNAI1.\",\n      \"evidence\": \"Lentiviral overexpression, siRNA knockdown, miRNA mimic transfection, Transwell assays in HCC cell lines\",\n      \"pmids\": [\"23691483\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Downstream effectors mediating migration suppression not identified\", \"No in vivo validation of miR-320–GNAI1 axis in tumors\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"The upstream regulators of GNAI1 in the nervous system and its connection to neurotrophic signaling were uncharacterized; valproic acid was shown to induce miR-124 which represses GNAI1, relieving adenylyl cyclase inhibition and increasing cAMP-dependent BDNF expression, defining a miR-124→GNAI1→cAMP→BDNF pathway.\",\n      \"evidence\": \"miRNA microarray, iTRAQ proteomics, miR-124 mimic/inhibitor transfection, Western blot and qRT-PCR in neural cells\",\n      \"pmids\": [\"26519098\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Pathway not validated in neurons in vivo\", \"Direct miR-124 binding to GNAI1 3′UTR not confirmed by reporter assay\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Whether Gαi proteins regulate inflammatory signaling beyond cAMP was unclear; GNAI1 and GNAI3 were shown to interact with IL-6 pathway components and suppress JAK2-driven NF-κB and STAT3 activation, with their loss causing MDSC expansion and compensatory GNAI2 upregulation in a colitis-associated cancer model.\",\n      \"evidence\": \"Co-IP, immunoblot, conditional KO mice (Gnai1/3-DKO, Gnai2 conditional in CD11c+ cells), flow cytometry, IL-6 antibody blockade\",\n      \"pmids\": [\"30836096\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct binding interface between GNAI1 and IL-6 pathway proteins not mapped\", \"Whether GNAI1 restrains JAK2 through Gβγ sequestration or direct inhibition is unresolved\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"The biochemical consequences of disease-associated GNAI1 mutations were unknown; the Gln52Pro variant was shown to abolish GTP binding and hydrolysis, disrupt partner protein interactions, and reduce plasma membrane localization, establishing that catalytic-site mutations cause loss of fundamental Gαi1 enzymatic function.\",\n      \"evidence\": \"In vitro GTP binding/hydrolysis assays, co-IP with partner proteins, cellular localization imaging of mutant vs. wild-type\",\n      \"pmids\": [\"34685729\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Only one variant characterized; generalizability across the variant spectrum not yet established\", \"Consequences for downstream GPCR signaling not measured\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Whether GNAI1 could be pharmacologically targeted was unexplored; puerarin was identified as a direct GNAI1-binding compound that inhibits its function, increasing cAMP and activating PKA/CREB signaling in podocytes to protect against high-glucose-induced apoptosis.\",\n      \"evidence\": \"DARTS-MS for direct binding, cAMP measurement, CREB phosphorylation assay, PKA inhibitor rescue, in vivo diabetic nephropathy mouse model\",\n      \"pmids\": [\"35678269\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Binding site on GNAI1 not mapped\", \"Selectivity of puerarin for GNAI1 over GNAI2/GNAI3 not assessed\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Whether the GNAI1–JAK2/STAT3 regulatory axis operates in the tumor microenvironment was unknown; exosomal miR-320d from colorectal cancer cells was shown to target GNAI1 in vascular endothelial cells, reducing GNAI1 and activating JAK2/STAT3-driven VEGFA production and angiogenesis.\",\n      \"evidence\": \"Luciferase reporter assay, miRNA mimic/inhibitor, endothelial tube formation/migration assays, in vivo tumor model\",\n      \"pmids\": [\"39695099\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether endothelial GNAI1 loss acts through cAMP or a cAMP-independent mechanism not dissected\", \"Contribution of GNAI1 vs. other miR-320d targets not isolated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Whether GNAI1 functions in ciliogenesis was unknown; patient-variant GNAI1 proteins were shown to fail ciliary localization in human cells, and corresponding C. elegans variants disrupted cilia assembly and sensory neuron function, establishing GNAI1 as a ciliogenesis-required gene with neuron-specific variant effects.\",\n      \"evidence\": \"CRISPR-Cas9 editing in C. elegans, cilia morphology assays, chemotaxis behavioral assays, ciliary localization imaging in human ciliated cell lines\",\n      \"pmids\": [\"41052774\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism by which Gαi1 promotes ciliogenesis (e.g., through Gβγ, cargo transport, or basal body docking) not identified\", \"Whether ciliary defects contribute to GNAI1 neurodevelopmental syndrome phenotypes in patients not established\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"How diverse GNAI1 syndrome variants alter GPCR signaling was unresolved; biochemical profiling revealed that most disease variants (T48K, T48I, C224Y, V332E) reduce GTP binding/hydrolysis yet paradoxically produce gain-of-function increases in dopamine D2R potency and constitutive G protein activity, while G40C is completely unresponsive to D2R, revealing variant-specific pathomechanisms.\",\n      \"evidence\": \"GTPγS binding/hydrolysis assays, Xenopus oocyte expression with D2R co-expression, constitutive activity measurements\",\n      \"pmids\": [\"41329793\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How reduced GTPase activity produces gain-of-function at receptor level mechanistically unexplained\", \"Whether gain-of-function signaling extends to other Gαi-coupled GPCRs beyond D2R not tested\", \"In vivo consequences of these biochemical alterations in neuronal circuits not demonstrated\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"GNAI1 regulation in skin biology was uncharacterized; miR-200a was shown to directly target the GNAI1 3′UTR, reducing GNAI1 expression and modulating melanogenesis in vivo.\",\n      \"evidence\": \"Dual-luciferase reporter assay with WT vs. mutant 3′UTR, miRNA mimic/inhibitor, antagomiR injection in mice\",\n      \"pmids\": [\"40394057\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether GNAI1-dependent melanogenesis regulation operates through cAMP/MITF axis not directly demonstrated\", \"Physiological relevance of miR-200a–GNAI1 axis in human pigmentation disorders unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include: the structural basis by which disease variants with impaired GTPase activity produce gain-of-function GPCR signaling; the mechanism by which Gαi1 is required for ciliogenesis; and whether the ciliary, signaling, and inflammatory regulatory roles of GNAI1 converge on a unified pathophysiological mechanism in GNAI1 neurodevelopmental syndrome.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No structural model of disease-variant Gαi1 in complex with D2R or ciliary machinery\", \"Relative contributions of cAMP-dependent vs. cAMP-independent functions of GNAI1 in neurons not dissected\", \"No patient-derived neuronal models tested\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [2, 8]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 3, 4, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005929\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [2, 8]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 3, 6, 8]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [0]},\n      {\"term_id\": \"R-HSA-112316\", \"supporting_discovery_ids\": [7, 8]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [7]}\n    ],\n    \"complexes\": [\n      \"Heterotrimeric Gi protein complex\"\n    ],\n    \"partners\": [\n      \"GNAI3\",\n      \"JAK2\",\n      \"NGB\",\n      \"DRD2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"GNAI1 encodes Gαi1, an inhibitory heterotrimeric G protein α-subunit that cycles between GDP-bound (inactive) and GTP-bound (active) states to transduce signals from Gi-coupled GPCRs, principally by inhibiting adenylyl cyclase and thereby lowering intracellular cAMP [PMID:8521505, PMID:35678269]. In its GDP-bound form, Gαi1 assembles with Gβ1γ2 into a heterotrimer; GTP binding triggers switch II rearrangement and βγ dissociation, while RGS proteins such as RGS10 accelerate GTP hydrolysis to terminate signaling [PMID:8521505, PMID:8774883]. Beyond classical GPCR transduction, Gαi1 participates in mitotic spindle positioning through the LGN–NuMA cortical complex [PMID:15537540], suppresses colitis-associated tumorigenesis by restraining JAK2/STAT3 and NF-κB signaling [PMID:30836096], and is required for ciliogenesis, with disease-associated missense variants disrupting GTP exchange, GTP hydrolysis, D2 receptor coupling, and ciliary localization, defining a neurodevelopmental GNAI1 syndrome [PMID:41329793, PMID:41052774, PMID:34685729].\",\n  \"teleology\": [\n    {\n      \"year\": 1995,\n      \"claim\": \"Resolution of the Gαi1·GDP–Gβ1γ2 heterotrimer crystal structure established the atomic basis for subunit assembly and revealed how GTP-induced switch II rearrangement drives subunit dissociation, providing the structural framework for all subsequent functional studies.\",\n      \"evidence\": \"X-ray crystallography at 2.3 Å resolution\",\n      \"pmids\": [\"8521505\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Structure captured the GDP-bound state; the active GTP-bound Gαi1 conformation with effectors was not resolved\",\n        \"No effector or GPCR complexes in the crystal\"\n      ]\n    },\n    {\n      \"year\": 1996,\n      \"claim\": \"Identification of RGS10 as a selective GAP for Gαi-family members demonstrated that signal termination is actively regulated and subfamily-specific, not merely a function of intrinsic GTP hydrolysis rates.\",\n      \"evidence\": \"Co-immunoprecipitation with activated Gα subunits plus in vitro GTPase assays with purified proteins\",\n      \"pmids\": [\"8774883\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"RGS10 selectivity was shown primarily for Gαi3, Gαz, and Gαo; direct GAP activity on Gαi1 specifically was not the focus\",\n        \"Cellular context for RGS10–Gαi1 regulation was not established\"\n      ]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"Discovery that Gαi1 binds the GoLoco domain of LGN to release NuMA and drive cortical spindle positioning revealed a GPCR-independent, cell-division-related function of Gαi1.\",\n      \"evidence\": \"Co-immunoprecipitation, FRET biosensor, and overexpression phenotypic analysis (spindle oscillations) in mammalian cells\",\n      \"pmids\": [\"15537540\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether endogenous Gαi1 versus other Gαi paralogs is the primary spindle-positioning subunit in vivo was not resolved\",\n        \"Upstream regulators of Gαi1-GDP loading at the cortex were not identified\"\n      ]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Demonstration that GNAI1 suppresses hepatocellular carcinoma cell migration and is post-transcriptionally repressed by miR-320a/c/d linked Gαi1 loss to tumor invasiveness.\",\n      \"evidence\": \"Lentiviral overexpression, siRNA knockdown, miRNA mimic transfection, Transwell assays in HCC cell lines\",\n      \"pmids\": [\"23691483\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Direct miRNA–3′UTR binding validation (e.g., luciferase reporter) was not shown\",\n        \"In vivo metastasis data were lacking\",\n        \"Downstream effectors mediating migration suppression were not defined\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Valproic acid–induced miR-124 was shown to repress GNAI1, relieving adenylyl cyclase inhibition and elevating cAMP/Bdnf, connecting Gαi1 to neurotrophin regulation via miRNA control.\",\n      \"evidence\": \"miRNA microarray, iTRAQ proteomics, miR-124 mimic/inhibitor transfection with Western blot and RT-qPCR readouts\",\n      \"pmids\": [\"26519098\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"No direct miR-124 binding assay for GNAI1 3′UTR\",\n        \"Functional consequence on neuronal phenotype (beyond Bdnf mRNA) not tested\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Genetic deletion of Gnai1 and Gnai3 in mice revealed that these subunits suppress colitis-associated tumorigenesis by restraining JAK2-mediated NF-κB and STAT3 activation downstream of IL-6, establishing Gαi1 as a tumor suppressor in inflammatory colon cancer.\",\n      \"evidence\": \"Double-knockout mouse model (DSS/AOM), co-IP, immunoblot, conditional Gnai2 rescue\",\n      \"pmids\": [\"30836096\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Individual contributions of Gnai1 versus Gnai3 were not fully separable\",\n        \"Direct physical interaction between Gαi1 and JAK2 was suggested by co-IP but structural details are absent\"\n      ]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Biochemical characterization of the Gln52Pro disease variant showed abolished GTP binding and hydrolysis and mislocalization away from the plasma membrane, providing the first molecular explanation for how a GNAI1 syndrome mutation disrupts G protein cycling.\",\n      \"evidence\": \"GTPase/GTP-binding assays, co-IP with partner proteins, subcellular localization imaging in transfected cells\",\n      \"pmids\": [\"34685729\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Only one variant characterized in detail; spectrum of other syndrome variants not addressed\",\n        \"No structural data explaining why Q52P blocks nucleotide binding\"\n      ]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Identification of puerarin as a direct Gαi1-binding ligand that relieves adenylyl cyclase inhibition in podocytes demonstrated pharmacological targeting of Gαi1 to increase cAMP/PKA/CREB signaling and protect against high-glucose-induced apoptosis.\",\n      \"evidence\": \"DARTS-mass spectrometry for direct binding; cAMP ELISA; CREB phosphorylation immunoblot; PKA inhibitor rescue\",\n      \"pmids\": [\"35678269\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Binding site on Gαi1 not mapped\",\n        \"Specificity of puerarin for Gαi1 versus other Gαi paralogs not determined\",\n        \"Single lab, awaits independent confirmation\"\n      ]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Exosomal miR-320d from colorectal cancer cells was shown to target GNAI1 in endothelial cells, activating JAK2/STAT3 and VEGFA to promote angiogenesis, extending the GNAI1–JAK2/STAT3 axis to the tumor microenvironment.\",\n      \"evidence\": \"Exosome transfer, miRNA mimic/inhibitor, GNAI1 knockdown/overexpression, in vivo mouse tumor model\",\n      \"pmids\": [\"39695099\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Mechanism by which GNAI1 restrains JAK2 in endothelial cells (direct interaction vs. indirect) not resolved\",\n        \"Single lab study\"\n      ]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Comprehensive functional profiling of GNAI1 syndrome variants revealed gain-of-function D2R signaling, disrupted GTP exchange/hydrolysis kinetics, and impaired ciliogenesis, unifying GPCR-transduction and ciliogenic defects as co-pathogenic mechanisms in the neurodevelopmental syndrome.\",\n      \"evidence\": \"Xenopus oocyte GIRK channel electrophysiology, GTPγS binding/hydrolysis assays, CRISPR knock-in C. elegans cilia phenotyping, human ciliated cell fluorescence microscopy\",\n      \"pmids\": [\"41329793\", \"41052774\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Neuronal-specific consequences of ciliary and D2R signaling defects in mammalian brain not tested\",\n        \"How variant-specific biochemical defects map onto clinical severity is unknown\",\n        \"Therapeutic rescue strategies not explored\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include which effector complexes Gαi1 engages in its GTP-bound form at atomic resolution, the paralog-specific contributions of Gαi1 versus Gαi2/Gαi3 in vivo, and whether pharmacological modulation of Gαi1 can ameliorate GNAI1 syndrome phenotypes.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No high-resolution structure of GTP-Gαi1 bound to an effector\",\n        \"Paralog-specific knockout phenotypes in the nervous system not fully characterized\",\n        \"No therapeutic intervention data for GNAI1 syndrome\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003924\", \"supporting_discovery_ids\": [0, 2, 3, 4]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 6, 8]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [4, 6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0, 3, 4]},\n      {\"term_id\": \"GO:0005929\", \"supporting_discovery_ids\": [5]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [0, 1, 2, 4, 6, 8]},\n      {\"term_id\": \"R-HSA-1640170\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [6]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 5, 6]}\n    ],\n    \"complexes\": [\n      \"Gαi1–Gβ1γ2 heterotrimer\",\n      \"LGN–NuMA spindle-positioning complex\"\n    ],\n    \"partners\": [\n      \"GNB1\",\n      \"GNG2\",\n      \"GPSM2\",\n      \"NUMA1\",\n      \"RGS10\",\n      \"JAK2\",\n      \"NGB\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}